CAS RN: 55438-65-8
1-(DIPHENYLMETHYL)-3-(MORPHOLINO)AZETIDINE
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260419
1g
Out of stock
1 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 55438-65-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
≥95%
0
Out of Stock
Beijing
Inquiry
55438-65-8 / 4-(1-benzhydrylazetidin-3-yl)morpholine
Standard CAS: 55438-65-8
Multi CAS: No
Basic Information
copy
CAS
55438-65-8 copy
Multi CAS
No copy
Molecular Formula
C20H24N2O copy
Molecular Weight
308.400000 copy
Exact Mass
308.188863 copy
InChI
InChI=1S/C20H24N2O/c1-3-7-17(8-4-1)20(18-9-5-2-6-10-18)22-15-19(16-22)21-11-13-23-14-12-21/h1-10,19-20H,11-16H2 copy
InChIKey
WESDDKGEBHTDKM-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
23 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.4 copy
Rotatable bonds
4 copy
H-bond acceptors
3 copy
Molar refractivity
92.48 copy
TPSA
15.71 copy
LogP / Solubility
WLOGP
2.79 copy
MLOGP
2.47 copy
XLogP3
3 copy
Consensus LogP
2.75 copy
Log S (ESOL)
-3.63 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.11 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.46 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.62 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
3 copy